Ireland
--:--IST
Latest
Clinical Trials in France / NCT04244721
Recruiting Not applicable

Effectiveness of a Parent-mediated Intervention With PACT on Children With ASD

NCT04244721 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2020-06-30
Last updated
2025-07-28

Condition(s) studied

Autism Spectrum Disorder

Investigational drug(s) / intervention(s)

Preschool Autism Communication Therapy (PACT)Treatment As Usual (TAU)

Preschool Autism Communication Therapy (PACT): Professionals guide parents in the PACT therapy by videoconference. Sessions between parent and professionals are every 15 days for 6 months. Each session lasts one hour. At the end of the 12 sessions, additional booster sessions (one session per month over 6 months) will allow parents to maintain their skills. Parents will use therapy with their children in daily home practice. The aims of PACT therapy is to improve synchrony in the communication between the child and the parents. Improvement of the synchrony will mediate the decrease of autism symptoms of the child.

Treatment As Usual (TAU): Children will receive therapies available in the community as speech language therapist or occupational therapist.

Study summary

Autism Spectrum Disorder (ASD) is a neuro-developmental disorders. There are different types of interventions. Among these interventions Early Start Denver Model (ESDM) and Preschool Autism Communication Therapy (PACT) have proved efficacy at short and long term. PACT is the therapy with the highest evidences when Parents delivered the intervention themselves.

Eligibility

Sex
ALL
Min age
18 Months
Max age
36 Months
Healthy volunteers
No
Inclusion Criteria: Child with autism Spectrum disorder * Symptoms in autism with a severity superior to 4 as measure by ADOS-2 * Positive ADI (Autism Diagnostic Interview) * Diagnostic done by a multidisciplinary team * Nonverbal IQ above 12 months Having health assurance Exclusion Criteria: For the child * Child with a twin brother or sister with ASD or having a brother or sister already included in this study * Epilepsy requiring medication * Severe hearing or visual impairment * Identification of a genetic anomaly causes participation in the intervention or validity of the data (determined by the principal investigator on a case-by-case basis) For the parents * Severe hearing or visual impairment * Severe psychiatric disorder * Unstable somatic disorders preventing intervention * Lack of Internet access * Parent not available for regular follow-up * Opposition of one parent to the child's participation in a study * Already receiving PACT therapy or any other intensive intervention (e.g. Denver)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hopital Vinatier Bron France Recruiting

More Hôpital le Vinatier trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04244721 on ClinicalTrials.gov ↗ ← All trials in France